A Phase III Study of Regional Radiation Therapy in Early Breast Cancer
Radiotherapy to the breast reduces the risk of cancer coming back for women with early breast cancer. This international study will determine if treating a larger area with radiotherapy can further improve the results.
Primary Sponsor
NCIC CTG
Collaborating Groups
Trans Tasman Radiation Oncology Group (TROG)
Final Accrual
180
Trial Chairperson
International: Prof Timothy J. Whelan
TROG: A/Prof Boon Chua
Trial Contact
ymurray@ctg.queensu.ca
Clinical Trial Registration
Related Post
21 April, 2025
Trial data-sharing made easier with HeSANDA initiative
Latest News: 21 April 2025 TROG Cancer Research is
16 April, 2025
Mark Hughes Foundation grant for innovative SMART trial into brain metastases
LATEST NEWS: 15 April 2025 An innovative trial aimed
